nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—migraine—Prednisone—psoriasis	0.395	1	CpDpCtD
Caffeine—CYP1A1—Clobetasol propionate—psoriasis	0.0448	0.115	CbGbCtD
Caffeine—CYP1A1—Methoxsalen—psoriasis	0.0236	0.0606	CbGbCtD
Caffeine—CYP2C8—Tazarotene—psoriasis	0.0211	0.0542	CbGbCtD
Caffeine—CYP3A5—Beclomethasone—psoriasis	0.0204	0.0524	CbGbCtD
Caffeine—CYP1A2—Clobetasol propionate—psoriasis	0.02	0.0515	CbGbCtD
Caffeine—CYP1A1—Cholecalciferol—psoriasis	0.0156	0.0401	CbGbCtD
Caffeine—CYP1B1—Dexamethasone—psoriasis	0.0154	0.0396	CbGbCtD
Caffeine—CYP1A2—Methoxsalen—psoriasis	0.0105	0.0271	CbGbCtD
Caffeine—CYP2D6—Hydroxyurea—psoriasis	0.00948	0.0244	CbGbCtD
Caffeine—CYP2C8—Cholecalciferol—psoriasis	0.009	0.0232	CbGbCtD
Caffeine—CYP3A7—Hydrocortisone—psoriasis	0.00869	0.0223	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00869	0.0223	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0082	0.0211	CbGbCtD
Caffeine—CYP3A7—Cyclosporine—psoriasis	0.0082	0.0211	CbGbCtD
Caffeine—CYP3A5—Mycophenolate mofetil—psoriasis	0.00812	0.0209	CbGbCtD
Caffeine—CYP2C8—Mycophenolate mofetil—psoriasis	0.00781	0.0201	CbGbCtD
Caffeine—CYP3A4—Calcitriol—psoriasis	0.00709	0.0182	CbGbCtD
Caffeine—CYP1A1—Dexamethasone—psoriasis	0.00675	0.0174	CbGbCtD
Caffeine—CYP3A5—Hydrocortisone—psoriasis	0.00652	0.0168	CbGbCtD
Caffeine—CYP2C9—Cholecalciferol—psoriasis	0.00628	0.0161	CbGbCtD
Caffeine—CYP2C8—Hydrocortisone—psoriasis	0.00626	0.0161	CbGbCtD
Caffeine—CYP3A5—Cyclosporine—psoriasis	0.00615	0.0158	CbGbCtD
Caffeine—CYP2C8—Cyclosporine—psoriasis	0.00592	0.0152	CbGbCtD
Caffeine—CYP2D6—Cholecalciferol—psoriasis	0.00574	0.0148	CbGbCtD
Caffeine—CYP3A4—Methoxsalen—psoriasis	0.00551	0.0142	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0054	0.0139	CbGbCtD
Caffeine—CYP3A7—Dexamethasone—psoriasis	0.0054	0.0139	CbGbCtD
Caffeine—ABCB1—Mycophenolate mofetil—psoriasis	0.00528	0.0136	CbGbCtD
Caffeine—CYP2E1—Dexamethasone—psoriasis	0.00521	0.0134	CbGbCtD
Caffeine—ABCB1—Betamethasone—psoriasis	0.00453	0.0117	CbGbCtD
Caffeine—ABCB1—Prednisolone—psoriasis	0.00447	0.0115	CbGbCtD
Caffeine—ABCB1—Hydrocortisone—psoriasis	0.00424	0.0109	CbGbCtD
Caffeine—ABCB1—Prednisone—psoriasis	0.00422	0.0109	CbGbCtD
Caffeine—CYP2C9—Cyclosporine—psoriasis	0.00413	0.0106	CbGbCtD
Caffeine—PIK3CA—skin epidermis—psoriasis	0.00406	0.155	CbGeAlD
Caffeine—CYP3A5—Dexamethasone—psoriasis	0.00405	0.0104	CbGbCtD
Caffeine—ABCB1—Cyclosporine—psoriasis	0.004	0.0103	CbGbCtD
Caffeine—CYP2C8—Dexamethasone—psoriasis	0.0039	0.01	CbGbCtD
Caffeine—CYP2D6—Cyclosporine—psoriasis	0.00377	0.0097	CbGbCtD
Caffeine—CYP3A4—Cholecalciferol—psoriasis	0.00365	0.00939	CbGbCtD
Caffeine—PIK3CD—endothelium—psoriasis	0.00341	0.13	CbGeAlD
Caffeine—CYP3A4—Triamcinolone—psoriasis	0.00317	0.00814	CbGbCtD
Caffeine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00317	0.00814	CbGbCtD
Caffeine—PIK3CB—endothelium—psoriasis	0.00298	0.114	CbGeAlD
Caffeine—PIK3CA—endothelium—psoriasis	0.00294	0.113	CbGeAlD
Caffeine—CYP2C9—Dexamethasone—psoriasis	0.00272	0.00699	CbGbCtD
Caffeine—CYP3A4—Betamethasone—psoriasis	0.00272	0.00698	CbGbCtD
Caffeine—CYP3A4—Prednisolone—psoriasis	0.00268	0.00689	CbGbCtD
Caffeine—ABCB1—Dexamethasone—psoriasis	0.00264	0.00678	CbGbCtD
Caffeine—CYP3A4—Hydrocortisone—psoriasis	0.00254	0.00653	CbGbCtD
Caffeine—CYP3A4—Prednisone—psoriasis	0.00253	0.00651	CbGbCtD
Caffeine—CYP2D6—Dexamethasone—psoriasis	0.00248	0.00639	CbGbCtD
Caffeine—CYP3A4—Cyclosporine—psoriasis	0.0024	0.00617	CbGbCtD
Caffeine—ABCB1—Methotrexate—psoriasis	0.00212	0.00545	CbGbCtD
Caffeine—ATM—skin of body—psoriasis	0.00164	0.0628	CbGeAlD
Caffeine—CYP3A4—Dexamethasone—psoriasis	0.00158	0.00406	CbGbCtD
Caffeine—PIK3CD—skin of body—psoriasis	0.00146	0.0557	CbGeAlD
Caffeine—PIK3CB—skin of body—psoriasis	0.00127	0.0486	CbGeAlD
Caffeine—PIK3CA—skin of body—psoriasis	0.00126	0.0481	CbGeAlD
Caffeine—PRKDC—tendon—psoriasis	0.00118	0.0452	CbGeAlD
Caffeine—PIK3CB—tendon—psoriasis	0.000967	0.037	CbGeAlD
Caffeine—CYP1A1—skin epidermis—psoriasis	0.000961	0.0367	CbGeAlD
Caffeine—PIK3CA—tendon—psoriasis	0.000957	0.0366	CbGeAlD
Caffeine—RYR1—tendon—psoriasis	0.000957	0.0366	CbGeAlD
Caffeine—ADORA1—tendon—psoriasis	0.000506	0.0193	CbGeAlD
Caffeine—PRKDC—Testosterone—Hydrocortisone—psoriasis	0.000436	0.214	CbGdCrCtD
Caffeine—CYP1B1—skin of body—psoriasis	0.000421	0.0161	CbGeAlD
Caffeine—PDE4B—tendon—psoriasis	0.000374	0.0143	CbGeAlD
Caffeine—PRKDC—Testosterone—Prednisolone—psoriasis	0.000366	0.18	CbGdCrCtD
Caffeine—PRKDC—Danazol—Hydrocortisone—psoriasis	0.000354	0.174	CbGdCrCtD
Caffeine—Deafness—Mycophenolic acid—psoriasis	0.000329	0.00359	CcSEcCtD
Caffeine—CYP1B1—tendon—psoriasis	0.000321	0.0123	CbGeAlD
Caffeine—Injury—Mycophenolic acid—psoriasis	0.00032	0.0035	CcSEcCtD
Caffeine—PRKDC—Norethindrone—Hydrocortisone—psoriasis	0.000319	0.157	CbGdCrCtD
Caffeine—Haemoglobin—Acitretin—psoriasis	0.000311	0.0034	CcSEcCtD
Caffeine—Haemorrhage—Acitretin—psoriasis	0.000309	0.00338	CcSEcCtD
Caffeine—PRKDC—Danazol—Prednisone—psoriasis	0.000305	0.15	CbGdCrCtD
Caffeine—Hypoglycaemia—Mycophenolic acid—psoriasis	0.000301	0.00329	CcSEcCtD
Caffeine—CYP1A1—skin of body—psoriasis	0.000298	0.0114	CbGeAlD
Caffeine—Urine output increased—Cyclosporine—psoriasis	0.000296	0.00324	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Mycophenolic acid—psoriasis	0.000294	0.00321	CcSEcCtD
Caffeine—Rash—Tazarotene—psoriasis	0.00029	0.00316	CcSEcCtD
Caffeine—Dermatitis—Tazarotene—psoriasis	0.000289	0.00316	CcSEcCtD
Caffeine—Hypersensitivity—Clobetasol propionate—psoriasis	0.000287	0.00313	CcSEcCtD
Caffeine—Pulmonary oedema—Mycophenolate mofetil—psoriasis	0.000285	0.00311	CcSEcCtD
Caffeine—Sepsis—Cyclosporine—psoriasis	0.000284	0.00311	CcSEcCtD
Caffeine—Immune system disorder—Acitretin—psoriasis	0.00028	0.00305	CcSEcCtD
Caffeine—Agitation—Calcitriol—psoriasis	0.000278	0.00304	CcSEcCtD
Caffeine—Sepsis—Mycophenolate mofetil—psoriasis	0.000277	0.00303	CcSEcCtD
Caffeine—Blood creatinine increased—Mycophenolic acid—psoriasis	0.000276	0.00301	CcSEcCtD
Caffeine—Infection—Methoxsalen—psoriasis	0.000275	0.00301	CcSEcCtD
Caffeine—Infestation—Hydroxyurea—psoriasis	0.000271	0.00296	CcSEcCtD
Caffeine—Infestation NOS—Hydroxyurea—psoriasis	0.000271	0.00296	CcSEcCtD
Caffeine—Skin disorder—Methoxsalen—psoriasis	0.000269	0.00294	CcSEcCtD
Caffeine—Malnutrition—Fluocinolone Acetonide—psoriasis	0.000269	0.00293	CcSEcCtD
Caffeine—Deafness—Cyclosporine—psoriasis	0.000266	0.00291	CcSEcCtD
Caffeine—Pulmonary oedema—Prednisolone—psoriasis	0.000266	0.0029	CcSEcCtD
Caffeine—Convulsion—Calcitriol—psoriasis	0.000262	0.00287	CcSEcCtD
Caffeine—Nervousness—Acitretin—psoriasis	0.000262	0.00286	CcSEcCtD
Caffeine—Hypertension—Calcitriol—psoriasis	0.000261	0.00286	CcSEcCtD
Caffeine—Gastritis—Mycophenolic acid—psoriasis	0.00026	0.00284	CcSEcCtD
Caffeine—Deafness—Mycophenolate mofetil—psoriasis	0.000259	0.00283	CcSEcCtD
Caffeine—Pulmonary oedema—Hydrocortisone—psoriasis	0.000259	0.00283	CcSEcCtD
Caffeine—Injury—Cyclosporine—psoriasis	0.000259	0.00283	CcSEcCtD
Caffeine—Hypersensitivity—Fluocinonide—psoriasis	0.000259	0.00283	CcSEcCtD
Caffeine—PRKDC—Levonorgestrel—Hydrocortisone—psoriasis	0.000254	0.125	CbGdCrCtD
Caffeine—Injury—Mycophenolate mofetil—psoriasis	0.000253	0.00276	CcSEcCtD
Caffeine—Rash—Clobetasol propionate—psoriasis	0.000246	0.00268	CcSEcCtD
Caffeine—Dermatitis—Clobetasol propionate—psoriasis	0.000245	0.00268	CcSEcCtD
Caffeine—Haemoglobin—Hydroxyurea—psoriasis	0.000244	0.00267	CcSEcCtD
Caffeine—Pulmonary oedema—Triamcinolone—psoriasis	0.000244	0.00267	CcSEcCtD
Caffeine—Hypoglycaemia—Cyclosporine—psoriasis	0.000244	0.00266	CcSEcCtD
Caffeine—Haemorrhage—Hydroxyurea—psoriasis	0.000243	0.00265	CcSEcCtD
Caffeine—Skin disorder—Calcitriol—psoriasis	0.00024	0.00262	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000239	0.00262	CcSEcCtD
Caffeine—Hypoglycaemia—Mycophenolate mofetil—psoriasis	0.000238	0.0026	CcSEcCtD
Caffeine—Injury—Prednisolone—psoriasis	0.000236	0.00257	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Mycophenolate mofetil—psoriasis	0.000232	0.00254	CcSEcCtD
Caffeine—Injury—Hydrocortisone—psoriasis	0.00023	0.00251	CcSEcCtD
Caffeine—Hyperglycaemia—Mycophenolic acid—psoriasis	0.000229	0.00251	CcSEcCtD
Caffeine—Infestation—Mycophenolic acid—psoriasis	0.000227	0.00248	CcSEcCtD
Caffeine—Infestation NOS—Mycophenolic acid—psoriasis	0.000227	0.00248	CcSEcCtD
Caffeine—Rash—Beclomethasone—psoriasis	0.000224	0.00244	CcSEcCtD
Caffeine—Dermatitis—Beclomethasone—psoriasis	0.000223	0.00244	CcSEcCtD
Caffeine—Blood creatinine increased—Cyclosporine—psoriasis	0.000223	0.00244	CcSEcCtD
Caffeine—Renal failure—Mycophenolic acid—psoriasis	0.000223	0.00243	CcSEcCtD
Caffeine—Pulmonary oedema—Dexamethasone—psoriasis	0.000222	0.00242	CcSEcCtD
Caffeine—Pulmonary oedema—Betamethasone—psoriasis	0.000222	0.00242	CcSEcCtD
Caffeine—Rash—Fluocinonide—psoriasis	0.000221	0.00242	CcSEcCtD
Caffeine—Dermatitis—Fluocinonide—psoriasis	0.000221	0.00242	CcSEcCtD
Caffeine—Infection—Acitretin—psoriasis	0.000218	0.00239	CcSEcCtD
Caffeine—Dry skin—Cyclosporine—psoriasis	0.000218	0.00238	CcSEcCtD
Caffeine—Infection—Fluocinolone Acetonide—psoriasis	0.000218	0.00238	CcSEcCtD
Caffeine—Blood creatinine increased—Mycophenolate mofetil—psoriasis	0.000217	0.00238	CcSEcCtD
Caffeine—Injury—Triamcinolone—psoriasis	0.000217	0.00237	CcSEcCtD
Caffeine—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.000215	0.00235	CcSEcCtD
Caffeine—Skin disorder—Acitretin—psoriasis	0.000214	0.00233	CcSEcCtD
Caffeine—Gastritis—Cyclosporine—psoriasis	0.000211	0.0023	CcSEcCtD
Caffeine—CYP2E1—tendon—psoriasis	0.000207	0.0079	CbGeAlD
Caffeine—Gastritis—Mycophenolate mofetil—psoriasis	0.000205	0.00224	CcSEcCtD
Caffeine—Haemoglobin—Mycophenolic acid—psoriasis	0.000205	0.00223	CcSEcCtD
Caffeine—Hypersensitivity—Methoxsalen—psoriasis	0.000204	0.00223	CcSEcCtD
Caffeine—Haemorrhage—Mycophenolic acid—psoriasis	0.000203	0.00222	CcSEcCtD
Caffeine—Irritability—Hydrocortisone—psoriasis	0.000202	0.00221	CcSEcCtD
Caffeine—Dry skin—Prednisolone—psoriasis	0.000198	0.00217	CcSEcCtD
Caffeine—Injury—Betamethasone—psoriasis	0.000197	0.00215	CcSEcCtD
Caffeine—Injury—Dexamethasone—psoriasis	0.000197	0.00215	CcSEcCtD
Caffeine—Dry skin—Hydrocortisone—psoriasis	0.000194	0.00212	CcSEcCtD
Caffeine—Pulmonary oedema—Prednisone—psoriasis	0.000193	0.00211	CcSEcCtD
Caffeine—Gastrointestinal disorder—Acitretin—psoriasis	0.00019	0.00207	CcSEcCtD
Caffeine—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000189	0.00207	CcSEcCtD
Caffeine—Cardiac disorder—Mycophenolic acid—psoriasis	0.000189	0.00206	CcSEcCtD
Caffeine—Sepsis—Prednisone—psoriasis	0.000188	0.00206	CcSEcCtD
Caffeine—Hyperglycaemia—Cyclosporine—psoriasis	0.000186	0.00203	CcSEcCtD
Caffeine—Infestation—Cyclosporine—psoriasis	0.000183	0.002	CcSEcCtD
Caffeine—Infestation NOS—Cyclosporine—psoriasis	0.000183	0.002	CcSEcCtD
Caffeine—Convulsion—Hydroxyurea—psoriasis	0.000183	0.002	CcSEcCtD
Caffeine—Hypersensitivity—Calcitriol—psoriasis	0.000182	0.00199	CcSEcCtD
Caffeine—Hyperglycaemia—Mycophenolate mofetil—psoriasis	0.000181	0.00198	CcSEcCtD
Caffeine—Renal failure—Cyclosporine—psoriasis	0.00018	0.00197	CcSEcCtD
Caffeine—Infestation NOS—Mycophenolate mofetil—psoriasis	0.000179	0.00195	CcSEcCtD
Caffeine—Infestation—Mycophenolate mofetil—psoriasis	0.000179	0.00195	CcSEcCtD
Caffeine—Malnutrition—Mycophenolic acid—psoriasis	0.000177	0.00194	CcSEcCtD
Caffeine—Renal failure—Mycophenolate mofetil—psoriasis	0.000176	0.00192	CcSEcCtD
Caffeine—Rash—Methoxsalen—psoriasis	0.000175	0.00191	CcSEcCtD
Caffeine—Dermatitis—Methoxsalen—psoriasis	0.000175	0.00191	CcSEcCtD
Caffeine—Irritability—Betamethasone—psoriasis	0.000172	0.00188	CcSEcCtD
Caffeine—Irritability—Dexamethasone—psoriasis	0.000172	0.00188	CcSEcCtD
Caffeine—Nervousness—Mycophenolic acid—psoriasis	0.000172	0.00188	CcSEcCtD
Caffeine—Infection—Hydroxyurea—psoriasis	0.000171	0.00187	CcSEcCtD
Caffeine—Injury—Prednisone—psoriasis	0.000171	0.00187	CcSEcCtD
Caffeine—Nervous system disorder—Hydroxyurea—psoriasis	0.000169	0.00185	CcSEcCtD
Caffeine—Skin disorder—Hydroxyurea—psoriasis	0.000168	0.00183	CcSEcCtD
Caffeine—Dry skin—Betamethasone—psoriasis	0.000166	0.00181	CcSEcCtD
Caffeine—Dry skin—Dexamethasone—psoriasis	0.000166	0.00181	CcSEcCtD
Caffeine—Haemoglobin—Cyclosporine—psoriasis	0.000165	0.00181	CcSEcCtD
Caffeine—Haemorrhage—Cyclosporine—psoriasis	0.000165	0.0018	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—psoriasis	0.000164	0.00179	CcSEcCtD
Caffeine—Infestation NOS—Hydrocortisone—psoriasis	0.000163	0.00178	CcSEcCtD
Caffeine—Infestation—Hydrocortisone—psoriasis	0.000163	0.00178	CcSEcCtD
Caffeine—Agitation—Mycophenolic acid—psoriasis	0.000163	0.00178	CcSEcCtD
Caffeine—Hypersensitivity—Acitretin—psoriasis	0.000162	0.00177	CcSEcCtD
Caffeine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000162	0.00176	CcSEcCtD
Caffeine—Haemoglobin—Mycophenolate mofetil—psoriasis	0.000161	0.00176	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—psoriasis	0.000161	0.00176	CcSEcCtD
Caffeine—Haemorrhage—Mycophenolate mofetil—psoriasis	0.000161	0.00175	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.000157	0.00172	CcSEcCtD
Caffeine—Sepsis—Methotrexate—psoriasis	0.000157	0.00172	CcSEcCtD
Caffeine—Rash—Calcitriol—psoriasis	0.000156	0.0017	CcSEcCtD
Caffeine—Dermatitis—Calcitriol—psoriasis	0.000156	0.0017	CcSEcCtD
Caffeine—Dyspnoea—Hydroxyurea—psoriasis	0.000154	0.00168	CcSEcCtD
Caffeine—Convulsion—Mycophenolic acid—psoriasis	0.000153	0.00168	CcSEcCtD
Caffeine—Hypertension—Mycophenolic acid—psoriasis	0.000153	0.00167	CcSEcCtD
Caffeine—Haemoglobin—Prednisolone—psoriasis	0.000151	0.00164	CcSEcCtD
Caffeine—Irritability—Prednisone—psoriasis	0.00015	0.00164	CcSEcCtD
Caffeine—Haemorrhage—Prednisolone—psoriasis	0.00015	0.00164	CcSEcCtD
Caffeine—Cardiac disorder—Mycophenolate mofetil—psoriasis	0.000149	0.00163	CcSEcCtD
Caffeine—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000149	0.00163	CcSEcCtD
Caffeine—Haemoglobin—Hydrocortisone—psoriasis	0.000147	0.00161	CcSEcCtD
Caffeine—Haemorrhage—Hydrocortisone—psoriasis	0.000146	0.0016	CcSEcCtD
Caffeine—Dry skin—Prednisone—psoriasis	0.000144	0.00158	CcSEcCtD
Caffeine—Infection—Mycophenolic acid—psoriasis	0.000144	0.00157	CcSEcCtD
Caffeine—Malnutrition—Cyclosporine—psoriasis	0.000143	0.00157	CcSEcCtD
Caffeine—Nervous system disorder—Mycophenolic acid—psoriasis	0.000142	0.00155	CcSEcCtD
Caffeine—Tachycardia—Mycophenolic acid—psoriasis	0.000141	0.00154	CcSEcCtD
Caffeine—Hyperglycaemia—Dexamethasone—psoriasis	0.000141	0.00154	CcSEcCtD
Caffeine—Hyperglycaemia—Betamethasone—psoriasis	0.000141	0.00154	CcSEcCtD
Caffeine—Skin disorder—Mycophenolic acid—psoriasis	0.00014	0.00153	CcSEcCtD
Caffeine—Malnutrition—Mycophenolate mofetil—psoriasis	0.00014	0.00153	CcSEcCtD
Caffeine—Nervousness—Cyclosporine—psoriasis	0.000139	0.00152	CcSEcCtD
Caffeine—Rash—Acitretin—psoriasis	0.000139	0.00151	CcSEcCtD
Caffeine—Dermatitis—Acitretin—psoriasis	0.000138	0.00151	CcSEcCtD
Caffeine—Haemoglobin—Triamcinolone—psoriasis	0.000138	0.00151	CcSEcCtD
Caffeine—Rash—Fluocinolone Acetonide—psoriasis	0.000138	0.00151	CcSEcCtD
Caffeine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000138	0.00151	CcSEcCtD
Caffeine—Haemorrhage—Triamcinolone—psoriasis	0.000138	0.0015	CcSEcCtD
Caffeine—Nervousness—Mycophenolate mofetil—psoriasis	0.000136	0.00148	CcSEcCtD
Caffeine—Immune system disorder—Hydrocortisone—psoriasis	0.000132	0.00144	CcSEcCtD
Caffeine—Agitation—Cyclosporine—psoriasis	0.000132	0.00144	CcSEcCtD
Caffeine—Dyspnoea—Mycophenolic acid—psoriasis	0.000129	0.00141	CcSEcCtD
Caffeine—Agitation—Mycophenolate mofetil—psoriasis	0.000128	0.0014	CcSEcCtD
Caffeine—Malnutrition—Hydrocortisone—psoriasis	0.000127	0.00139	CcSEcCtD
Caffeine—Hypersensitivity—Hydroxyurea—psoriasis	0.000127	0.00139	CcSEcCtD
Caffeine—Haemoglobin—Dexamethasone—psoriasis	0.000126	0.00137	CcSEcCtD
Caffeine—Haemoglobin—Betamethasone—psoriasis	0.000126	0.00137	CcSEcCtD
Caffeine—Irritability—Methotrexate—psoriasis	0.000126	0.00137	CcSEcCtD
Caffeine—Haemorrhage—Betamethasone—psoriasis	0.000125	0.00137	CcSEcCtD
Caffeine—Haemorrhage—Dexamethasone—psoriasis	0.000125	0.00137	CcSEcCtD
Caffeine—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000125	0.00136	CcSEcCtD
Caffeine—Convulsion—Cyclosporine—psoriasis	0.000124	0.00136	CcSEcCtD
Caffeine—Hypertension—Cyclosporine—psoriasis	0.000124	0.00135	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—psoriasis	0.000123	0.00134	CcSEcCtD
Caffeine—Convulsion—Mycophenolate mofetil—psoriasis	0.000121	0.00132	CcSEcCtD
Caffeine—Hypertension—Mycophenolate mofetil—psoriasis	0.000121	0.00132	CcSEcCtD
Caffeine—Infection—Cyclosporine—psoriasis	0.000116	0.00127	CcSEcCtD
Caffeine—Nervous system disorder—Cyclosporine—psoriasis	0.000115	0.00125	CcSEcCtD
Caffeine—Skin disorder—Cyclosporine—psoriasis	0.000114	0.00124	CcSEcCtD
Caffeine—Infection—Mycophenolate mofetil—psoriasis	0.000113	0.00124	CcSEcCtD
Caffeine—Convulsion—Prednisolone—psoriasis	0.000113	0.00123	CcSEcCtD
Caffeine—Hypertension—Prednisolone—psoriasis	0.000113	0.00123	CcSEcCtD
Caffeine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000112	0.00122	CcSEcCtD
Caffeine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000111	0.00122	CcSEcCtD
Caffeine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000111	0.00121	CcSEcCtD
Caffeine—Convulsion—Hydrocortisone—psoriasis	0.00011	0.00121	CcSEcCtD
Caffeine—Hypertension—Hydrocortisone—psoriasis	0.00011	0.0012	CcSEcCtD
Caffeine—Haemoglobin—Prednisone—psoriasis	0.000109	0.0012	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—psoriasis	0.000109	0.00119	CcSEcCtD
Caffeine—Rash—Hydroxyurea—psoriasis	0.000109	0.00119	CcSEcCtD
Caffeine—Dermatitis—Hydroxyurea—psoriasis	0.000109	0.00119	CcSEcCtD
Caffeine—Dyspnoea—Cyclosporine—psoriasis	0.000104	0.00114	CcSEcCtD
Caffeine—Convulsion—Triamcinolone—psoriasis	0.000104	0.00114	CcSEcCtD
Caffeine—Tachycardia—Prednisolone—psoriasis	0.000104	0.00113	CcSEcCtD
Caffeine—Hypertension—Triamcinolone—psoriasis	0.000104	0.00113	CcSEcCtD
Caffeine—Infection—Hydrocortisone—psoriasis	0.000103	0.00113	CcSEcCtD
Caffeine—Nervous system disorder—Hydrocortisone—psoriasis	0.000102	0.00111	CcSEcCtD
Caffeine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000102	0.00111	CcSEcCtD
Caffeine—Tachycardia—Hydrocortisone—psoriasis	0.000101	0.00111	CcSEcCtD
Caffeine—Infestation—Methotrexate—psoriasis	0.000101	0.00111	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—psoriasis	0.000101	0.00111	CcSEcCtD
Caffeine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000101	0.0011	CcSEcCtD
Caffeine—Skin disorder—Hydrocortisone—psoriasis	0.000101	0.0011	CcSEcCtD
Caffeine—Renal failure—Methotrexate—psoriasis	9.96e-05	0.00109	CcSEcCtD
Caffeine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.85e-05	0.00108	CcSEcCtD
Caffeine—Immune system disorder—Prednisone—psoriasis	9.83e-05	0.00107	CcSEcCtD
Caffeine—Infection—Triamcinolone—psoriasis	9.72e-05	0.00106	CcSEcCtD
Caffeine—Tachycardia—Triamcinolone—psoriasis	9.55e-05	0.00104	CcSEcCtD
Caffeine—Malnutrition—Prednisone—psoriasis	9.48e-05	0.00104	CcSEcCtD
Caffeine—Convulsion—Dexamethasone—psoriasis	9.43e-05	0.00103	CcSEcCtD
Caffeine—Convulsion—Betamethasone—psoriasis	9.43e-05	0.00103	CcSEcCtD
Caffeine—Hypertension—Dexamethasone—psoriasis	9.39e-05	0.00103	CcSEcCtD
Caffeine—Hypertension—Betamethasone—psoriasis	9.39e-05	0.00103	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—psoriasis	9.14e-05	0.000999	CcSEcCtD
Caffeine—Rash—Mycophenolic acid—psoriasis	9.12e-05	0.000996	CcSEcCtD
Caffeine—Dermatitis—Mycophenolic acid—psoriasis	9.11e-05	0.000995	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—psoriasis	9.1e-05	0.000994	CcSEcCtD
Caffeine—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.97e-05	0.00098	CcSEcCtD
Caffeine—Infection—Dexamethasone—psoriasis	8.82e-05	0.000964	CcSEcCtD
Caffeine—Infection—Betamethasone—psoriasis	8.82e-05	0.000964	CcSEcCtD
Caffeine—Dyspnoea—Triamcinolone—psoriasis	8.73e-05	0.000953	CcSEcCtD
Caffeine—Nervous system disorder—Dexamethasone—psoriasis	8.71e-05	0.000951	CcSEcCtD
Caffeine—Nervous system disorder—Betamethasone—psoriasis	8.71e-05	0.000951	CcSEcCtD
Caffeine—Agitation—Prednisone—psoriasis	8.71e-05	0.000951	CcSEcCtD
Caffeine—Tachycardia—Dexamethasone—psoriasis	8.67e-05	0.000947	CcSEcCtD
Caffeine—Tachycardia—Betamethasone—psoriasis	8.67e-05	0.000947	CcSEcCtD
Caffeine—Hypersensitivity—Cyclosporine—psoriasis	8.62e-05	0.000941	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—psoriasis	8.44e-05	0.000922	CcSEcCtD
Caffeine—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.41e-05	0.000918	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—psoriasis	8.22e-05	0.000898	CcSEcCtD
Caffeine—Convulsion—Prednisone—psoriasis	8.21e-05	0.000897	CcSEcCtD
Caffeine—Hypertension—Prednisone—psoriasis	8.18e-05	0.000894	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—psoriasis	7.92e-05	0.000865	CcSEcCtD
Caffeine—Hypersensitivity—Prednisolone—psoriasis	7.84e-05	0.000857	CcSEcCtD
Caffeine—Infection—Prednisone—psoriasis	7.68e-05	0.000839	CcSEcCtD
Caffeine—Gastrointestinal disorder—Betamethasone—psoriasis	7.67e-05	0.000838	CcSEcCtD
Caffeine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.67e-05	0.000838	CcSEcCtD
Caffeine—Hypersensitivity—Hydrocortisone—psoriasis	7.66e-05	0.000837	CcSEcCtD
Caffeine—Nervous system disorder—Prednisone—psoriasis	7.58e-05	0.000829	CcSEcCtD
Caffeine—Tachycardia—Prednisone—psoriasis	7.55e-05	0.000825	CcSEcCtD
Caffeine—Skin disorder—Prednisone—psoriasis	7.51e-05	0.000821	CcSEcCtD
Caffeine—Rash—Cyclosporine—psoriasis	7.37e-05	0.000806	CcSEcCtD
Caffeine—Dermatitis—Cyclosporine—psoriasis	7.37e-05	0.000805	CcSEcCtD
Caffeine—Hypersensitivity—Triamcinolone—psoriasis	7.21e-05	0.000788	CcSEcCtD
Caffeine—Rash—Mycophenolate mofetil—psoriasis	7.19e-05	0.000786	CcSEcCtD
Caffeine—Dermatitis—Mycophenolate mofetil—psoriasis	7.19e-05	0.000785	CcSEcCtD
Caffeine—Convulsion—Methotrexate—psoriasis	6.86e-05	0.00075	CcSEcCtD
Caffeine—Rash—Prednisolone—psoriasis	6.71e-05	0.000733	CcSEcCtD
Caffeine—Dermatitis—Prednisolone—psoriasis	6.7e-05	0.000732	CcSEcCtD
Caffeine—Rash—Hydrocortisone—psoriasis	6.55e-05	0.000716	CcSEcCtD
Caffeine—Dermatitis—Hydrocortisone—psoriasis	6.55e-05	0.000715	CcSEcCtD
Caffeine—Infection—Methotrexate—psoriasis	6.42e-05	0.000701	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—psoriasis	6.34e-05	0.000692	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—psoriasis	6.28e-05	0.000686	CcSEcCtD
Caffeine—Rash—Triamcinolone—psoriasis	6.17e-05	0.000674	CcSEcCtD
Caffeine—Dermatitis—Triamcinolone—psoriasis	6.17e-05	0.000674	CcSEcCtD
Caffeine—Dyspnoea—Methotrexate—psoriasis	5.76e-05	0.00063	CcSEcCtD
Caffeine—Hypersensitivity—Prednisone—psoriasis	5.7e-05	0.000622	CcSEcCtD
Caffeine—Rash—Dexamethasone—psoriasis	5.6e-05	0.000612	CcSEcCtD
Caffeine—Rash—Betamethasone—psoriasis	5.6e-05	0.000612	CcSEcCtD
Caffeine—Dermatitis—Betamethasone—psoriasis	5.59e-05	0.000611	CcSEcCtD
Caffeine—Dermatitis—Dexamethasone—psoriasis	5.59e-05	0.000611	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—psoriasis	5.58e-05	0.00061	CcSEcCtD
Caffeine—Rash—Prednisone—psoriasis	4.88e-05	0.000533	CcSEcCtD
Caffeine—Dermatitis—Prednisone—psoriasis	4.87e-05	0.000532	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—psoriasis	4.76e-05	0.00052	CcSEcCtD
Caffeine—Rash—Methotrexate—psoriasis	4.08e-05	0.000445	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—psoriasis	4.07e-05	0.000445	CcSEcCtD
Caffeine—PIK3CA—Immune System—HLA-B—psoriasis	1.39e-05	0.000144	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL6—psoriasis	1.37e-05	0.000143	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—CD4—psoriasis	1.37e-05	0.000142	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—TP53—psoriasis	1.36e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—APOE—psoriasis	1.35e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—IL6—psoriasis	1.35e-05	0.00014	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—TNF—psoriasis	1.34e-05	0.00014	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NDUFA5—psoriasis	1.34e-05	0.00014	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.34e-05	0.000139	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—SOCS1—psoriasis	1.34e-05	0.000139	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—TYK2—psoriasis	1.34e-05	0.000139	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SOCS1—psoriasis	1.32e-05	0.000138	CbGpPWpGaD
Caffeine—PIK3CB—Disease—NOS2—psoriasis	1.31e-05	0.000136	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP2S1—psoriasis	1.31e-05	0.000136	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-A—psoriasis	1.29e-05	0.000134	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—JUN—psoriasis	1.27e-05	0.000132	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—TYK2—psoriasis	1.27e-05	0.000132	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—CXCL8—psoriasis	1.27e-05	0.000132	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NDUFA5—psoriasis	1.27e-05	0.000132	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—TYK2—psoriasis	1.26e-05	0.000131	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NDUFA5—psoriasis	1.26e-05	0.00013	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IFNG—psoriasis	1.25e-05	0.00013	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.25e-05	0.00013	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—VEGFA—psoriasis	1.24e-05	0.000129	CbGpPWpGaD
Caffeine—PIK3CD—Disease—TYK2—psoriasis	1.23e-05	0.000128	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CRP—psoriasis	1.23e-05	0.000128	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—NFKB1—psoriasis	1.23e-05	0.000127	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—CXCL8—psoriasis	1.22e-05	0.000127	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.000126	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—CXCL8—psoriasis	1.21e-05	0.000126	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD4—psoriasis	1.21e-05	0.000125	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—CAT—psoriasis	1.2e-05	0.000124	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.19e-05	0.000124	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HLA-A—psoriasis	1.19e-05	0.000123	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—TP53—psoriasis	1.19e-05	0.000123	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—APOE—psoriasis	1.18e-05	0.000123	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PPARG—psoriasis	1.18e-05	0.000122	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—NFKB1—psoriasis	1.18e-05	0.000122	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-DRB1—psoriasis	1.18e-05	0.000122	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.17e-05	0.000122	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—TYK2—psoriasis	1.16e-05	0.000121	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP2S1—psoriasis	1.14e-05	0.000119	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—CARM1—psoriasis	1.13e-05	0.000118	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—LEP—psoriasis	1.13e-05	0.000118	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—APOE—psoriasis	1.13e-05	0.000118	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—ICAM1—psoriasis	1.13e-05	0.000117	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SOCS1—psoriasis	1.13e-05	0.000117	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—IL6—psoriasis	1.12e-05	0.000117	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NFKBIA—psoriasis	1.12e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CD4—psoriasis	1.11e-05	0.000116	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—IL6—psoriasis	1.11e-05	0.000116	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SOCS1—psoriasis	1.11e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CA—Disease—APOE—psoriasis	1.11e-05	0.000115	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CXCL8—psoriasis	1.11e-05	0.000115	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CXCL8—psoriasis	1.1e-05	0.000114	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IFNG—psoriasis	1.09e-05	0.000113	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—JUN—psoriasis	1.08e-05	0.000112	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.08e-05	0.000112	CbGpPWpGaD
Caffeine—PIK3CB—Disease—TYK2—psoriasis	1.07e-05	0.000112	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.000112	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NDUFA5—psoriasis	1.07e-05	0.000111	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP2S1—psoriasis	1.07e-05	0.000111	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—TYK2—psoriasis	1.06e-05	0.00011	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.00011	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NFKBIA—psoriasis	1.05e-05	0.00011	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SOCS1—psoriasis	1.05e-05	0.000109	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD4—psoriasis	1.05e-05	0.000109	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—NFKB1—psoriasis	1.04e-05	0.000108	CbGpPWpGaD
Caffeine—PIK3CA—Disease—NOS2—psoriasis	1.03e-05	0.000107	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000107	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PPARG—psoriasis	1.03e-05	0.000107	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CARM1—psoriasis	1.02e-05	0.000106	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL6—psoriasis	1.02e-05	0.000106	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CXCL8—psoriasis	1.02e-05	0.000106	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—TYK2—psoriasis	1e-05	0.000104	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—LEP—psoriasis	9.86e-06	0.000102	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—APOE—psoriasis	9.86e-06	0.000102	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—IL6—psoriasis	9.77e-06	0.000102	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—APOE—psoriasis	9.77e-06	0.000102	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—LEP—psoriasis	9.77e-06	0.000102	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CD4—psoriasis	9.72e-06	0.000101	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CXCL8—psoriasis	9.62e-06	0.0001	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—JUN—psoriasis	9.42e-06	9.79e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—STAT3—psoriasis	9.35e-06	9.72e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—TP53—psoriasis	9.35e-06	9.71e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CXCL8—psoriasis	9.34e-06	9.71e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—APOE—psoriasis	9.29e-06	9.66e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CXCL8—psoriasis	9.23e-06	9.59e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NFKBIA—psoriasis	9.19e-06	9.55e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—TYK2—psoriasis	9.17e-06	9.53e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP2S1—psoriasis	9.12e-06	9.48e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NFKBIA—psoriasis	9.1e-06	9.46e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—NFKB1—psoriasis	9.07e-06	9.42e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	8.86e-06	9.2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CXCL8—psoriasis	8.74e-06	9.08e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SOCS1—psoriasis	8.69e-06	9.03e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TYK2—psoriasis	8.63e-06	8.97e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—STAT3—psoriasis	8.63e-06	8.97e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IFNG—psoriasis	8.59e-06	8.92e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.53e-06	8.86e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TYK2—psoriasis	8.47e-06	8.8e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—LEP—psoriasis	8.31e-06	8.63e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—APOE—psoriasis	8.31e-06	8.63e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD4—psoriasis	8.29e-06	8.62e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—TYK2—psoriasis	8.29e-06	8.61e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NDUFA5—psoriasis	8.28e-06	8.6e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—LEP—psoriasis	8.21e-06	8.53e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—APOE—psoriasis	8.21e-06	8.53e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—STAT3—psoriasis	8.15e-06	8.47e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PPARG—psoriasis	8.09e-06	8.41e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CXCL8—psoriasis	7.94e-06	8.26e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—APOE—psoriasis	7.77e-06	8.07e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—LEP—psoriasis	7.77e-06	8.07e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NFKBIA—psoriasis	7.74e-06	8.04e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.74e-06	8.04e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—IL6—psoriasis	7.7e-06	8e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CD4—psoriasis	7.66e-06	7.96e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NFKBIA—psoriasis	7.65e-06	7.95e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TYK2—psoriasis	7.52e-06	7.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—STAT3—psoriasis	7.52e-06	7.82e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CXCL8—psoriasis	7.52e-06	7.81e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.5e-06	7.79e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TYK2—psoriasis	7.46e-06	7.75e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—JUN—psoriasis	7.42e-06	7.71e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CARM1—psoriasis	7.41e-06	7.7e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CARM1—psoriasis	7.39e-06	7.68e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NFKBIA—psoriasis	7.24e-06	7.52e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CXCL8—psoriasis	7.21e-06	7.5e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—IL6—psoriasis	7.15e-06	7.43e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NFKB1—psoriasis	7.15e-06	7.43e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2S1—psoriasis	7.04e-06	7.31e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—JUN—psoriasis	6.99e-06	7.26e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CARM1—psoriasis	6.98e-06	7.26e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—CAT—psoriasis	6.98e-06	7.25e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.87e-06	7.14e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NFKB1—psoriasis	6.73e-06	6.99e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.63e-06	6.89e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCL8—psoriasis	6.55e-06	6.81e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL6—psoriasis	6.53e-06	6.79e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.53e-06	6.79e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCL8—psoriasis	6.49e-06	6.75e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—STAT3—psoriasis	6.42e-06	6.67e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—APOE—psoriasis	6.41e-06	6.66e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—LEP—psoriasis	6.41e-06	6.66e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CARM1—psoriasis	6.4e-06	6.65e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TYK2—psoriasis	6.34e-06	6.59e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CAT—psoriasis	6.29e-06	6.54e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TYK2—psoriasis	6.26e-06	6.51e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—IL6—psoriasis	6.23e-06	6.47e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—IL6—psoriasis	6.17e-06	6.41e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—VEGFA—psoriasis	6.1e-06	6.34e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—JUN—psoriasis	6.09e-06	6.33e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—STAT3—psoriasis	6.04e-06	6.28e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—JUN—psoriasis	6.03e-06	6.27e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—IL6—psoriasis	6.03e-06	6.27e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.99e-06	6.22e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NFKBIA—psoriasis	5.98e-06	6.21e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TYK2—psoriasis	5.93e-06	6.16e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—STAT3—psoriasis	5.93e-06	6.16e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NFKB1—psoriasis	5.86e-06	6.09e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.85e-06	6.08e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NFKB1—psoriasis	5.81e-06	6.04e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL6—psoriasis	5.69e-06	5.92e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.59e-06	5.81e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CARM1—psoriasis	5.58e-06	5.8e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCL8—psoriasis	5.52e-06	5.74e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCL8—psoriasis	5.45e-06	5.67e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—APOE—psoriasis	5.42e-06	5.63e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—VEGFA—psoriasis	5.32e-06	5.53e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—VEGFA—psoriasis	5.27e-06	5.48e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—STAT3—psoriasis	5.27e-06	5.48e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CARM1—psoriasis	5.26e-06	5.46e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—IL6—psoriasis	5.26e-06	5.46e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL6—psoriasis	5.25e-06	5.45e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—STAT3—psoriasis	5.22e-06	5.43e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CARM1—psoriasis	5.21e-06	5.42e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL6—psoriasis	5.19e-06	5.39e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCL8—psoriasis	5.16e-06	5.37e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—JUN—psoriasis	5.13e-06	5.33e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—JUN—psoriasis	5.07e-06	5.27e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NFKB1—psoriasis	4.94e-06	5.13e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL6—psoriasis	4.91e-06	5.1e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TYK2—psoriasis	4.89e-06	5.09e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—APOE—psoriasis	4.89e-06	5.08e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NFKB1—psoriasis	4.88e-06	5.07e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.87e-06	5.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—JUN—psoriasis	4.8e-06	4.99e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.78e-06	4.97e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PPARG—psoriasis	4.72e-06	4.91e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NFKB1—psoriasis	4.62e-06	4.8e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—psoriasis	4.61e-06	4.79e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CAT—psoriasis	4.56e-06	4.74e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CAT—psoriasis	4.55e-06	4.73e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL6—psoriasis	4.49e-06	4.66e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—psoriasis	4.48e-06	4.66e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CARM1—psoriasis	4.45e-06	4.63e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—STAT3—psoriasis	4.44e-06	4.61e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—psoriasis	4.43e-06	4.6e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—STAT3—psoriasis	4.39e-06	4.56e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CAT—psoriasis	4.3e-06	4.46e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL8—psoriasis	4.26e-06	4.43e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARG—psoriasis	4.26e-06	4.42e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—psoriasis	4.22e-06	4.39e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—psoriasis	4.19e-06	4.36e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.16e-06	4.33e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—STAT3—psoriasis	4.15e-06	4.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—psoriasis	4.14e-06	4.3e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—psoriasis	4.05e-06	4.21e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—psoriasis	4.02e-06	4.18e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—psoriasis	3.98e-06	4.14e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—JUN—psoriasis	3.96e-06	4.12e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CAT—psoriasis	3.94e-06	4.09e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NFKB1—psoriasis	3.81e-06	3.96e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—psoriasis	3.68e-06	3.82e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—psoriasis	3.65e-06	3.79e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—APOE—psoriasis	3.54e-06	3.68e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—APOE—psoriasis	3.53e-06	3.67e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—psoriasis	3.46e-06	3.6e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CARM1—psoriasis	3.44e-06	3.57e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CAT—psoriasis	3.43e-06	3.57e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—psoriasis	3.43e-06	3.56e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—psoriasis	3.39e-06	3.52e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—psoriasis	3.35e-06	3.48e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—APOE—psoriasis	3.34e-06	3.47e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CAT—psoriasis	3.23e-06	3.36e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CAT—psoriasis	3.21e-06	3.33e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—psoriasis	3.17e-06	3.29e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—psoriasis	3.1e-06	3.22e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARG—psoriasis	3.08e-06	3.21e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARG—psoriasis	3.08e-06	3.2e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—psoriasis	3.06e-06	3.18e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—APOE—psoriasis	3.06e-06	3.18e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARG—psoriasis	2.91e-06	3.02e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—psoriasis	2.9e-06	3.01e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CAT—psoriasis	2.74e-06	2.85e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—APOE—psoriasis	2.67e-06	2.77e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARG—psoriasis	2.67e-06	2.77e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—psoriasis	2.62e-06	2.72e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—APOE—psoriasis	2.51e-06	2.61e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—APOE—psoriasis	2.49e-06	2.59e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—psoriasis	2.39e-06	2.49e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARG—psoriasis	2.32e-06	2.41e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARG—psoriasis	2.19e-06	2.27e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARG—psoriasis	2.17e-06	2.25e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—APOE—psoriasis	2.13e-06	2.21e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CAT—psoriasis	2.11e-06	2.2e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARG—psoriasis	1.85e-06	1.93e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—APOE—psoriasis	1.64e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARG—psoriasis	1.43e-06	1.49e-05	CbGpPWpGaD
